investment & stocks ideas
investment & stocks ideas
Favourites   Have ideas?  Sign in / Register

Positive:   Immunology ↓5.08   Pharmaceutical  ↓3.64   Equipment ↓2.44 «See more»   Disease: Oncology ↑2.78   Acquisitions/Investing ↑3.21   Healthcare ↑3.76

Life Sciences stock segment: trending tickers

ACTG Acacia Research Corporation - Common Stock -0.36% -0.36% 0 + Acquisitions/Investing, Technology, Life Sciences, Finance

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/934549/000093454924000048/0000934549-24-000048-index.htm
8-K - ACACIA RESEARCH CORP (0000934549) (Filer)
+ My List
ATNFW 180 Life Sciences Corp. - Warrant 0.00% 0 + Life Sciences, Medicine
+ My List
IDXG Interpace Biosciences, Inc. - Common Stock 2.78% 2.78% 0 + Medicine, Disease: Oncology, Cancer fight, Life Sciences

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/1054102/000149315224018432/0001493152-24-018432-index.htm
10-Q - INTERPACE BIOSCIENCES, INC. (0001054102) (Filer)
+ My List
LFVN Lifevantage Corporation - Common Stock 2.31% 2.31% 0 + Healthcare, Life Sciences, 1% Dividends

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/849146/000084914624000039/0000849146-24-000039-index.htm
8-K - Lifevantage Corp (0000849146) (Filer)
+ My List
NDRA ENDRA Life Sciences Inc. - Common Stock 0.00% 0 + Life Sciences, Disease: Liver

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1681682/000165495424006635/0001654954-24-006635-index.htm
8-K - ENDRA Life Sciences Inc. (0001681682) (Filer)
+ My List
OPRX OptimizeRx Corporation - Common Stock 5.2% 5.2% 0 + Healthcare, Life Sciences, SaaS

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/1448431/000121390024043749/0001213900-24-043749-index.htm
10-Q - OptimizeRx Corp (0001448431) (Filer)
+ My List
RSSS Research Solutions, Inc - Common Stock -3.64% -3.64% 0 + Life Sciences, SaaS, Pharmaceutical

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/1305168/000130516824000049/0001305168-24-000049-index.htm
10-Q - ARC DOCUMENT SOLUTIONS, INC. (0001305168) (Filer)
+ My List
TOMZ TOMI Environmental Solutions, Inc. - Common Stock -2.44% -2.44% 0 + Disease: Infectious, Medicine, Equipment, Life Sciences, Food, Covid (fighting)

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/314227/000165495424002073/0001654954-24-002073-index.htm
8-K - TOMI Environmental Solutions, Inc. (0000314227) (Filer)
+ My List
WVE Wave Life Sciences Ltd. - Ordinary Shares 2.13% 2.13% 0 + Medicine, Biotechnology, Life Sciences

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/1631574/000095017024057457/0000950170-24-057457-index.htm
10-Q - Wave Life Sciences Ltd. (0001631574) (Filer)
+ My List
XGN Exagen Inc. - Common Stock -5.08% -5.08% 0 + Life Sciences, Medicine, Immunology

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/1274737/000127473724000048/0001274737-24-000048-index.htm
10-Q - EXAGEN INC. (0001274737) (Filer)
+ My List
MASS 908 Devices Inc. - Common Stock -1.37% -1.37% 0 + Devices, Biopharma, Life Sciences

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/1555279/000155837024006601/0001558370-24-006601-index.htm
10-Q - 908 Devices Inc. (0001555279) (Filer)
+ My List
VINC Vincerx Pharma, Inc. - Common Stock -2.86% -2.86% 0 + Biopharma, Medicine, Life Sciences

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/1796129/000119312524138276/0001193125-24-138276-index.htm
10-Q - Vincerx Pharma, Inc. (0001796129) (Filer)
+ My List
ALPP Alpine 4 Holdings, Inc. - Class A Common Stock 6.78% 6.78% 0 + Acquisitions/Investing, Life Sciences

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1606698/000109690624001182/0001096906-24-001182-index.htm
8-K - ALPINE 4 HOLDINGS, INC. (0001606698) (Filer)
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.